McDonough Geoff

DirectorGeneration Bio Co. (GBIO) · full profile →Form 4 · filed Feb 9, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
3 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Tender(U)138K0
Feb 9, 2026Tender(U)28K0
Feb 9, 2026Tender(U)23K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Disposed to issuer(D)20K0
Feb 9, 2026Disposed to issuer(D)25K0
Feb 9, 2026Disposed to issuer(D)37K0
Feb 9, 2026Disposed to issuer(D)24K0
Feb 9, 2026Disposed to issuer(D)90K0
Feb 9, 2026Disposed to issuer(D)17K0
Feb 9, 2026Disposed to issuer(D)51K0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-012192) within minutes of acceptance. Every field above traces to the original document. Verify it directly: